As of Apr 24
| -0.03 / -0.41%|
The 4 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 8.50, with a high estimate of 11.00 and a low estimate of 8.00. The median estimate represents a +16.76% increase from the last price of 7.28.
The current consensus among 4 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.